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Abstract
Background: Obesity-induced hepatic lipid accumulation causes lipotoxicity, mitochondrial dysfunction, oxidative
stress, and insulin resistance, and is implicated in non-alcoholic hepatic pathologies such as steatohepatitis and
fibrosis. Heme oxygenase-1 (HO-1), an important antioxidant enzyme catalyzing the rate-limiting step in heme
degradation, protects against oxidative stress, inflammation, and metabolic dysregulation. Here, we demonstrate
that the phytochemical, quercetin, a natural polyphenol flavonoid, protects against hepatic steatosis in obese mice
fed a high-fat diet, and that it does so by inducing HO-1 and stimulating increased hepatic mitochondrial oxidative
metabolism.
Methods: Male C57BL/6 mice were fed a regular diet (RD), a high-fat diet (HFD), and an HFD supplemented with
quercetin for 9 weeks. Levels of mitochondrial biogenesis and oxidative metabolic transcripts/proteins were
measured by real-time PCR and/or Western blotting. HO-1 transcripts/proteins were measured real-time PCR and/or
Western blotting.
Results: Quercetin upregulated genes involved in mitochondrial biogenesis and oxidative metabolism in lipid-laden
hepatocytes and the livers of HFD-fed obese mice, and this was accompanied by increased levels of the transcription
factor, nuclear erythroid 2-related factor 2 (Nrf-2), and HO-1 protein. The HO-1 inducer hemin and the HO-1 byproduct
carbon monoxide (CO) also enhanced hepatic oxidative metabolism in HFD-fed obese mice. Moreover, the metabolic
changes and the lipid-lowering effects of quercetin were completely blocked by the HO-1 inhibitor ZnPP and by
deficiency of Nrf-2.
Conclusion: These findings suggest that quercetin stimulates hepatic mitochondrial oxidative metabolism by inducing
HO-1 via the Nrf-2 pathway. Quercetin may be useful in protecting against obesity-induced hepatosteatosis.
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Background
Obesity is a major risk factor for non-alcoholic fatty liver
diseases (NAFLD), a condition ranging from excess trigly-
ceride accumulation as lipid droplets within hepatocytes
(fatty liver/steatosis) to steatohepatitis, which is accom-
panied by hepatocyte injury and inflammation, cell death,
and fibrosis [1] and increases the risk of progression to
cirrhosis as well as hepatocellular carcinoma [2]. Obesity-
induced hepatic lipid accumulation results from uptake of
circulating free fatty acids and de novo hepatic lipogenesis,
leading to lipotoxicity, mitochondrial dysfunction, oxida-
tive stress, and insulin resistance [1]. In addition, the re-
duction in mitochondrial oxidative metabolism leads to
accumulation of partially oxidized intermediates, which
further exacerbates insulin resistance and promotes the
development of NAFLD [3, 4]. Hence, improving mito-
chondrial function and biogenesis in obese conditions
might be beneficial in protecting against the development
and progression of NAFLD.
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Heme oxygenase-1 (HO-1), an important antioxidant en-
zyme catalyzing the rate-limiting step in heme degradation,
is one of factors protecting against oxidative stress, inflam-
mation, and metabolic dysregulation [5, 6]. HO-1 expres-
sion is regulated by the activation of nuclear factor
erythroid 2-related factor 2 (Nrf-2), a basic leucine zipper
transcription factor [7]. Carbon monoxide (CO), a bypro-
duct of HO-1 activity increases mitochondrial biogenesis by
binding to cytochrome c oxidase and stimulating mito-
chondrial ROS production [8]; it is therefore implicated in
mitochondrial oxidative phosphorylation. Moreover, we
and others have reported that HO-1 induction by hemin
protects against obesity-induced metabolic dysregulation by
reducing adipose inflammation [9], which causes mitochon-
drial dysfunction leading to loss of oxidative capacity and
hepatic lipid accumulation [4, 10]. We therefore hypothe-
sized that dietary factors that promote HO-1 induction
and/or Nrf-2 activation might help to maintain hepatic
mitochondrial oxidative capacity in obese conditions.
Quercetin (3, 3, 4, 5, 7-pentahydroxyflavone) is a fla-
vonoid that is abundant in various fruits and vegetables
and stimulates antioxidant and anti-inflammatory activ-
ities [11–14]. We previously showed that it decreased
chemokine-induced adipose inflammatory responses by
inhibiting the activation of inflammatory signaling mole-
cules [15], and protected against obesity-induced skeletal
muscle inflammation [16]. It also reduced ethanol-
derived oxidative stress in human hepatocytes [17], and
stimulated mitochondrial biogenesis in HepG2 cells and
lipopolysaccharide-injected mice [18]. It has been sug-
gested that its protective effect is due to HO-1 induction
[18]. Quercetin also reduced the expression of genes en-
coding lipogenic enzymes in rat-liver cells and diet-
induced obese mice [19, 20]. However, its effects on hep-
atic mitochondrial oxidative metabolism in obese condi-
tion remain unclear.
In this study, we demonstrate that quercetin reduces
lipid accumulation in primary hepatocytes and the
livers of obese mice fed a high-fat diet, and that this is
associated with enhanced hepatic mitochondrial oxida-
tive metabolism and HO-1 induction. The metabolic
effects of quercetin were blocked by an HO-1 inhibitor
and Nrf-2 deficiency. These findings indicate that the
beneficial action of quercetin is associated with HO-1
induction through the Nrf-2 pathway. Quercetin may




All animal experiments were approved by the animal
ethics committee of the University of Ulsan, and conformed
to National Institutes of Health guidelines. Six-week-old
male C57BL/6 mice were purchased from Orient Ltd.
(Orient, Busan, Korea). The mice were maintained
under specific pathogen-free conditions at 22 °C and
given access to food and water ad libitum.
To examine the effects of quercetin on obesity-induced
liver disease, we started the quercetin supplementation to-
gether with the establishment of diet-induced obesity.
Mice (C57BL/6, male) were adapted for 1 week and then
randomly divided into four dietary groups (n = 6 per
group) and fed for 9 weeks on (1) a regular diet (RD)
(3.1 kcal/g; 18 % calories from soybean oil; 58 % as carbo-
hydrate; 24 % as protein; Harlan Teklad, Madison, WI);
(2) a high-fat diet (HFD) (5.24 kcal/g; 60 % calories from
lard and soybean oil; 20 % as carbohydrate; 20 % as pro-
tein; Research Diets, New Brunswick, NJ); (3) the HFD
supplemented with 0.05 % (w/w) quercetin (HFD + 0.05 %
Que); and (4) the HFD supplemented with 0.1 % quercetin
(HFD + 0.1 % Que). The dosages of quercetin are equiva-
lent to previous studies [16, 18], which are calculated to
be ~50 and 100 mg/kg body weight per day, respectively.
To evaluate the effect of hemin on obesity-induced
liver disease, mice were randomly assigned to the follow-
ing experimental groups (n = 5 per group): (1) the RD +
vehicle (RD), (2) the HFD + vehicle (HFD), and (3) the
HFD +Hemin. Hemin (Sigma-Aldrich, St. Louis, MO)
was dissolved in 0.15 M NaCl plus 10 % ammonium hy-
droxide (NH4OH) as a stock solution of 100 mg/mL and
then further diluted 1 : 40 with sterile 0.15 M NaCl. The
diluter was intraperitoneally injected (25 mg/kg BW)
into the mice three times per week for 2 weeks [9, 21].
Vehicle-injected mice received an identical NH4OH-
containing solution lacking hemin.
To evaluate the effect of CO, on obesity-induced liver
disease, mice were randomly assigned to the following
experimental groups (n = 6–7 per group): (1) the RD + air
(RD), (2) the HFD + air (HFD), and (3) the HFD + carbon
monoxide (HFD + CO). Mice inhaled CO (250 ppm) in
air (Core Gas Ulsan, Korea) for 2 h (10 AM-12 PM)
each day for 10 week. Mice were placed in an exposure
chamber (LB science, Daejeon, Korea) at room temperature
for exposure to air (control) or to 250 ppm CO as moni-
tored by a CO probe (Tongoy Control Technology, Beijing,
China) [22].
Isolation of hepatocytes
Cultures of mouse hepatocytes were prepared as previously
described [23]. Briefly, C57BL/6 male mice or Nrf-2 defi-
cient mice (B6/SJL background), 6–8 weeks old, were anes-
thetized with Nembutal (Dainippon Sumitomo Pharma,
Japan) intraperitonealy and their livers were perfused with
40 ml of Liver Perfusion Medium (Gibco, Grand Island,
NY) followed by 30 ml of Liver Digestion Medium (Gibco),
both at a flow rate of 5 ml/min. Hepatocytes were dis-
persed in Hepatocyte Wash Medium (Gibco) supple-
mented with 1 % penicillin/streptomycin by dissection and
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gentle shaking. After filtration through a 100 μm nylon
mesh filter, hepatocytes were purified by repeated centrifu-
gation (three times) at 50 × g for 2 min. A typical yield was
about 4–5 × 107 hepatocytes/mouse with >80 % cell viabil-
ity as determined by trypan blue exclusion assay. The pur-
ity of hepatocytes was determined by flow cytometry
(FACSCanto II, BD Bioscience, San Jose, CA). Hepato-
cytes and non-hepatocytes were separated based on
cell size using forward scatter (FSC) and side scatter
(SSC). Data were analyzed with Diva Software (BD Bio-
science), and 85 % of the cells were found to be hepa-
tocytes. The isolated hepatocytes were resuspended in
DMEM (Gibco) supplemented with 10 % FBS, and 1 %
penicillin/streptomycin, and cultured in type-1 collagen-
coated 12-well plates at a cell density of 2 × 105 cells/well.
Cell culture and treatment of hepatocytes
To establish lipid-laden hepatocyte, mouse primary hepa-
tocytes on 12-well plates (2 × 105 cells) were treated with
1 mM FFA mixture, a 2:1 ratio of oleate/palmitate coupled
to fatty acid-free BSA (molar ratio, 10:1) in DMEM sup-
plemented with 10 % FBS, and 1 % penicillin/streptomycin
for 24 h. The cells were exposed to various concentrations
of quercetin and/or 0.1 μM ZnPP, an HO-1 inhibitor for
24 h incubation.
Fasting glucose and insulin levels, and glucose tolerance
tests
Plasma insulin levels were determined with the Ultrasensi-
tive Mouse Insulin ELISA (Mercodia, Uppsala, Sweden),
and glucose levels were determined with an Accu-Chek
glucose monitor and test strips (Roche Diagnostics, In-
dianapolis, IN). For oral glucose tolerance tests, mice
were fasted 12 h before receiving by oral administration
of a 20 % glucose solution at a dose of 2 g/kg. Blood
samples were taken from tail veins at before and 30,
60, 90, and 120 min after glucose administration and
analyzed for glucose levels.
Determination of lipid peroxidation
Hepatic lipid peroxidation levels were determined by meas-
uring the levels of thiobarbituric acid-reactive substances
(TBARS). Briefly, samples were mixed with TBA reagent
consisting of thiobarbituric acid (TBA) and 15 %
trichloroacetic acid in 0.25M HCl. The reaction mixture
was boiled in a water bath for 1 h and centrifuged at
2000 rpm for 10 min. The TBARS concentration was deter-
mined at 520 nm absorbance with tetra-methoxypropane as
standard. The protein content of homogenates was deter-
mined with a BCA protein assay kit (Pierce, Rockford, IL).
Hepatic histology
Liver tissues were fixed overnight at room temperature
in 10 % formaldehyde and embedded in paraffin. Eight
micron thick sections were stained with hematoxylin-
eosin and mounted on glass slides. Stained sections were
viewed with an Axio-Star Plus microscope (original mag-
nification ×200; Carl Zeiss, Gottingen, Germany).
Hepatic lipid levels
Hepatic triglyceride content was assayed by saponifi-
cation in ethanolic KOH, and glycerol content was
measured with an FG0100 kit (Sigma-Aldrich) after
neutralization with MgCl2. All tissue triglyceride
values were converted to glycerol content and cor-
rected for liver weight. Plasma alanine aminotransfer-
ase (ALT) level was measured using commercial kits
(Asan Pharm. Co., LTD, Gyeonggi-do, Korea).
Real-time PCR
Total RNA extracted from cultured cells was reverse
transcribed into cDNA using M-MLV reverse transcript-
ase (Promega, Madison, WI). Real-time PCR amplifica-
tion of the cDNA was performed in duplicate with a
SYBR premix Ex Taq kit (TaKaRa Bio Inc., Foster, CA)
using a Thermal Cycler Dice (TaKaRa Bio Inc., Japan).
All reactions were performed by the same procedure:
initial denaturation at 95 °C for 10 s, followed by 45 cy-
cles of 95 °C for 5 s and 60 °C for 30 s. Results were ana-
lyzed with real-time system TP800 software (Takara Bio,
Inc.) and all values for genes were normalized to values
for a housekeeping gene. The primers used in the analysis
are listed in Table 1.
Western blot analysis
Samples of 10 ~ 50 μg total protein were subjected to
western blot analysis using polyclonal antibodies to
phosphorylated Akt (Akt-pSer473), Akt (Cell Signaling,
Beverly, MA), HO-1 (Enzo Life Sciences, Farmingdale,
NY), COX IV (Abcam, Cambridge, MA), α-Tubulin
(Abcam), and β-actin (Sigma-Aldrich). Protein bands
were detected using an enhanced chemiluminescence
Western blotting detection kit (PerkinElmer, Waltham,
MA). Band intensities were quantified by densitometry
using Image J program.
Statistical analyses
Results are presented as means ± SEM. Statistical ana-
lyses were performed using Student’s t test. Differences
were considered to be significant at p < 0.05.
Results
Effect of quercetin on hepatic steatosis and glucose
intolerance in obese mice fed an HFD
To examine the effects of quercetin in vivo, we gener-
ated obese mice fed an HFD with or without quercetin.
Quercetin supplementation significantly reduced hepatic
triglyceride concentration in the liver of the HFD-fed
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obese mice (Fig. 1a). In agreement with this, lipid depos-
ition in the liver revealed by histochemical analysis was
reduced (Fig. 1b). Quercetin also significantly reduced
TBARS levels, a marker of lipid peroxidation (Fig. 1c),
and ALT levels, a marker of liver damage (Fig. 1d). We
further examined whether the metabolic improvement
in response to quercetin observed in the livers of the
obese mice reduced obesity-induced glucose intolerance.
Levels of fasting glucose and insulin were significantly
lower by quercetin (Fig.1e). Glucose tolerance tests con-
firmed that the quercetin-fed obese mice were more glu-
cose tolerant (Fig. 1f ), and activation of the insulin
Table 1 Mouse primers used for real-time PCR analysis










Fig. 1 Effect of quercetin on hepatic lipid accumulation and glucose tolerance in HFD-fed obese mice. C57BL/6 mice were fed a regular diet
(RD), a high-fat diet (HFD), an HFD supplemented with 0.05 % quercetin (HF + 0.05 % Que) or 0.1 % quercetin (HFD + 0.1 % Que) for 9 weeks
(n = 6 per group). a Liver tissues were collected and their TG content was determined. b Representative images of hematoxylin and eosin stained
tissue. Original magnification, 200 ×. c Hepatic TBARS levels as a marker of lipid peroxidation. d Plasma alanine aminotransferase (ALT) levels. Data
are mean ± SEM of six mice per group. *p < 0.05, **p < 0.01 versus HFD. e Fasting glucose and insulin levels. f Oral glucose tolerance test. Mice
were fasted 12 h before receiving by mouth a 20 % glucose solution at a dose of 2 g/kg, and blood samples were taken at the indicated times.
Levels of glucose were measured using the glucometer. Data are mean ± SEM of six mice per group. *p < 0.05, # p < 0.005 versus HFD.
g Insulin responses. After fasting 5 h, mice were stimulated with or without insulin for 4 min. Expression of p-Akt, and Akt proteins in the liver,
adipose tissue, and skeletal muscle of each mouse (n = 4 per group) were examined by Western blot analysis using the indicated antibodies.
Data are mean ± SEM of four mice per group. *p < 0.05 versus HFD
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signaling molecules Akt in liver, muscle, and adipose tis-
sue was stimulated (Fig. 1g). Quercetin did not alter food
intake, and the HFD-fed mice supplemented with quer-
cetin had a tendency to gain less weight than the control
HFD-fed mice (data not shown), as previously reported
[16], indicating that the observed benefits of quercetin
supplementation are probably associated with the meta-
bolic effects of quercetin.
Induction of HO-1 by quercetin in liver of obese mice fed
an HFD
HO-1 plays an important role in modulating hepatic me-
tabolism by affecting mitochondrial biogenesis and metab-
olism [24, 25]. We found that quercetin supplementation
significantly upregulated levels of Nrf-2 and HO-1
transcripts (Fig. 2a), and also increased HO-1 protein
in the HFD-fed obese mice (Fig. 2b). To see whether it
altered mitochondrial oxidative metabolism, we mea-
sured markers for mitochondrial biogenesis and oxida-
tive phosphorylation. Levels of PGC-1α and Tfam
transcripts (Fig. 2c), and COX IV protein (Fig. 2d) were
indeed also upregulated.
HO-1 inhibition and Nrf-2 deficiency oppose the effects of
quercetin
Using lipid-laden primary hepatocytes mimicking fatty
hepatocytes, we tested the idea that quercetin reduces
hepatic lipid accumulation by inducing HO-1. As shown
in Fig. 3a and b, the effect of quercetin on the lipid content
of lipid-laden hepatocytes was paralleled by an increase in
Fig. 2 Effect of quercetin on expression of HO-1 and/or mitochondrial biogenesis markers in HFD-fed obese mice. Livers were isolated from mice
fed a regular diet (RD), a high-fat diet (HFD), an HFD supplemented with 0.05 % quercetin (HF + 0.05 % Que) or 0.1 % quercetin (HFD + 0.1 % Que) for
9 weeks (n = 6 per group). a Expression of Nrf-2 and HO-1 mRNAs was quantified by real-time PCR. b Levels of HO-1 protein were determined
by Western blotting. c Expression of PGC-1α, Nrf-1, and Tfam mRNAs was quantified by real-time PCR. d Levels of COX IV protein were
determined by Western blotting. Data are mean ± SEM of six mice per group. *p < 0.05, **p < 0.01 versus HFD
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the level of HO-1 protein. Along with this we found that
markers of mitochondrial biogenesis such as PGC-1α, and
PPARα and CTP-1α, a marker of mitochondrial oxidative
phosphorylation, were upregulated (Fig. 3c). Moreover,
ZnPP, a competitive inhibitor of HO-1, significantly re-
duced these effects (Fig. 3c), and the effects were com-
pletely abolished in Nrf-2 deficiency (Fig. 3d). Moreover,
quercetin also had no effect on HO-1 protein levels in the
Nrf-2-deficient hepatocytes, while it markedly induced
HO-1 expression in the WTcontrol (Fig. 3e).
Effect of hemin and carbon monoxide on hepatic
mitochondrial metabolism
We also confirmed the effects of the HO-1 inducer hemin
and the HO-1 byproduct carbon monoxide on hepatic lipid
content in HFD-fed obese mice. Like quercetin, both treat-
ments reduced hepatic lipid accumulation (Fig. 4a and d)
and enhanced markers of mitochondria biogenesis
such as Tfam and PGC-1α transcripts (Fig. 4b and e) as
well as a marker of oxidative metabolism, COX IV protein
(Fig. 4c and f) in the livers of HFD-fed obese mice.
Discussion
The uptake of circulating free fatty acids together with
de novo hepatic lipogenesis can lead to harmful hepatic
lipid accumulation. Hence, identifying dietary factors
that reduce hepatic lipogenesis and/or increase hepatic
lipid oxidation may be useful in reducing hepatic lipid
accumulation in obese condition. Quercetin reduces the
biosynthesis of hepatic fatty acids and triglycerides in
the liver of HFD-fed mice [19]. In this study, we showed
that quercetin enhances hepatic mitochondrial oxidative
metabolism in lipid-laden hepatocytes and the livers of
obese mice fed a high-fat diet, and for the first time
demonstrated a causal relationship between the expres-
sion of Nrf-2/HO-1, mitochondrial biogenesis and hep-
atic lipid accumulation using hemin, ZnPP and CO.
Upregulation of transcripts and proteins involved in
mitochondrial biogenesis leads to enhancement of oxida-
tive metabolic capacity. For example, the transcription
factor Nrf-1 regulates the transcription of nuclear genes
coding for mitochondrial respiratory chain proteins, and
it can be activated by PGC-1α, which stimulates the
Fig. 3 Effects of quercetin on lipid accumulation and HO-1 induction in hepatocytes. a-b Mouse primary hepatocytes were incubated with a
1 mM FFA mixture (2:1 ratio of oleate/palmitate) for 24 h, and exposed to various concentrations of quercetin. N-hepa was added with 100 μM
BSA. N-hepa; normal hepatocyte, F-hepa; fatty hepatocytes. a Intracellular TG content. Data are mean ± SEM of quadruplicate samples. *p < 0.05,
## p < 0.001 versus F-hepa. b HO-1 protein was determined by Western blotting. Data are mean ± SEM from two independent experiments.
*p < 0.05, **p<0.01 versus F-hepa. c-d Mouse primary hepatocytes from Nrf-2 deficient and WT mice were incubated with 1 mM FFA
mixture (2:1 ratio of oleate/palmitate) for 24 h and exposed 10 μM quercetin and/or 0.1 μM ZnPP, an HO-1 inhibitor. Control cells were
incubated with FFA mixture. c Wild type lipid-laden hepatocytes. d Nrf-2 deficient lipid-laden hepatocytes. Expressions of mRNAs associated with lipid
oxidation (PPARα and CPT-1α) and mitochondrial biogenesis (PGC-1α) were quantified by real-time PCR. Data are mean ± SEM from three independent
experiments. *p < 0.05, ## p < 0.001 versus Que. e HO-1 protein was determined by Western blotting. Data are mean ± SEM from four independent
experiments. *p < 0.05 versus WT-Con
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transcription of genes involved in oxidative phos-
phorylation [26, 27]. PGC-1α and Nrf-1 coactivate
the expression of Tfam, which is important for regu-
lating and maintaining mtDNA replication and tran-
scription [26, 27]. Moreover, increases of COX IV
typically reflect increased levels of other mitochon-
drial enzymes of the electron transport chain and en-
zymes of the β-oxidation pathway [28]. In this study,
we found that quercetin increased transcript levels of
genes involved in regulating mitochondria biogenesis
such as PGC-1α, Nrf-1, Tfam, as well as COX IV
protein in HFD-fed obese mice and in lipid-laden he-
patocytes. Others have shown that obesity-induced
reduction of transcript of PPARα, which regulates β-
oxidation, is prevented by quercetin supplementation
[19, 29]. Our findings together with these others sug-
gest that quercetin improves hepatic mitochondrial
oxidative metabolic capacity by increasing mitochon-
dria biogenesis, and so limits hepatic lipid accumula-
tion. Alternatively, quercetin is a potent scavenger of
ROS in many types of cells [30–32], and this may
contribute to reduction of mitochondrial oxidative
damage and hence maintain its oxidative metabolic
capacity. In addition, the reductions in TBARS and
plasma levels of ALT indicate that quercetin protects
against hepatic mitochondrial damage, which may
rescue mitochondrial oxidative capacity.
HO-1 metabolizes heme to biliverdin and releases car-
bon monoxide and iron [33], and plays an important
role in cellular defense against oxidative damage and in
cellular metabolism [25]. The transcription factor Nrf-2
is the master regulator of HO-1 gene expression, and
the HO-1 product, carbon monoxide, enhances the nu-
clear translocation of Nrf-1 and PGC-1α, and activates
Tfam expression, all of which augments mitochondrial
biogenesis [34, 35]. Studies have shown that quercetin
attenuates hepatic lipid accumulation in obese mice fed
an HFD [19, 31, 32] and that reduced lipid accumulation
is associated with Nrf-2 [31]. Quercetin also increases
hepatic mitochondrial biogenesis [18]. However, the link
between hepatic lipid accumulation and mitochondrial
biogenesis and Nrf-2/HO-1 signaling remained unclear.
Interestingly, we observed upregulation of HO-1 protein
in the livers of obese mice supplemented with quercetin
and in lipid-laden hepatocytes treated with quercetin.
Moreover, we found that the HO-1 inducer hemin
and the HO-1 byproduct carbon monoxide enhanced
levels of transcripts involved in mitochondria biogen-
esis and oxidative phosphorylation, and reduced hep-
atic lipid accumulation, indicating that the effect of
Fig. 4 Effect of an HO-1 inducer and/or CO on hepatic lipid accumulation and mitochondrial oxidative metabolism in HFD-fed mice (a-c) C57BL/
6 mice were fed an HFD diet for 2 weeks with hemin injection three times per week (n = 5 per group). a Liver tissues were collected and their TG
contents were determined. b PGC-1α, Nrf-1, and Tfam mRNAs were quantified by real-time PCR. c Expression levels of COX IV protein was determined
by Western blotting. Data are mean ± SEM of five mice per group. *p < 0.05 versus HFD. d-f C57BL/6 mice inhaled CO (250 ppm) for 2 h each day for
10 weeks (n = 6–7 per group). d Liver tissues were collected and their TG contents were determined. e PGC-1α, Nrf-1, and Tfam mRNAs were
quantified by real-time PCR. f Expression levels of COX IV protein were determined by Western blotting. Data are mean ± SEM of six to
seven mice per group. *p < 0.05, # p < 0.005 versus HFD
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quercetin may be due to HO-1 induction. Moreover
the beneficial metabolic effect of quercetin on hepatic
mitochondrial metabolic markers was abrogated by
the HO-1 inhibitor ZnPP in lipid-laden hepatocytes.
Quercetin also upregulated Nrf-2, a transcriptional
regulator of HO-1, suggesting that quercetin-induced
HO-1 upregulation is mediated by the Nrf-2 pathway.
Indeed, we found that the effects of quercetin on the
induction of HO-1 were completely disrupted in Nrf-
2 deficient lipid-laden hepatocytes, and this was ac-
companied by a reduction in mitochondrial oxidative
metabolic transcripts. These results suggest that one
of the mechanisms by which quercetin enhances
mitochondrial oxidative metabolism is associated with
HO-1 induction through Nrf-2 pathway (Fig. 5).
Conclusion
In conclusion, quercetin reduced obesity-induced hep-
atic lipid accumulation by enhancing mitochondrial oxi-
dative capacity, and this was accompanied by induction
of HO-1. The action of quercetin was blunted by HO-1
inhibitor and Nrf-2 deficiency, indicating that HO-1 in-
duction by quercetin through Nrf-2 pathway may be
among mechanisms contributing to the reduction of
obesity-induced hepatic lipid accumulation. Quercetin,
an inducer of HO-1, may be useful as a dietary factor for
reducing obesity-induced hepatosteatosis.
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Fig. 5 Proposed mechanism for quercetin action against hepatic steatosis in obese mice. Excess intake of nutrients, including overloaded FFAs in
obese conditions, increases ROS production in the liver; the latter results from lipid peroxidation and cause mitochondrial damage. The mitochondrial
damage in turn leads to a decrease of mitochondrial oxidative capacity, including β-oxidation and ATP production, resulting in triglyceride
accumulation in the liver. Quercetin limits hepatic lipid accumulation by enhancing hepatic mitochondrial oxidative metabolic capacity.
Quercetin increases the induction of HO-1 and its byproduct CO by the upregulated transcriptional regulator Nrf-2. CO, enhances the nuclear
translocation of Nrf-1 and PGC-1α, and activates Tfam expression, all of which augments mitochondrial biogenesis. This leads to reduction of FFA-
induced lipid peroxidation, mitochondrial damage and hepatic triglyceride accumulation by increasing mitochondrial oxidative capacity. The effects of
quercetin on the induction of HO-1 were completely disrupted in HO-1 inhibitor and/or Nrf-2 deficiency, indicating that one of the mechanisms by
which quercetin enhances mitochondrial oxidative metabolism is associated with HO-1 induction through Nrf-2 pathway
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